• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Aortic Stiffness in Patients With Inflammatory Bowel Disease Reduced After Anti-Tumor Necrosis Factor Therapy.

作者信息

Zanoli Luca, Inserra Gaetano, Cappello Maria, Ozturk Kadir, Castellino Pietro

出版信息

J Am Coll Cardiol. 2019 Mar 5;73(8):981-982. doi: 10.1016/j.jacc.2018.12.032.

DOI:10.1016/j.jacc.2018.12.032
PMID:30819367
Abstract
摘要

相似文献

1
Aortic Stiffness in Patients With Inflammatory Bowel Disease Reduced After Anti-Tumor Necrosis Factor Therapy.抗肿瘤坏死因子治疗后炎症性肠病患者的主动脉僵硬度降低
J Am Coll Cardiol. 2019 Mar 5;73(8):981-982. doi: 10.1016/j.jacc.2018.12.032.
2
Tumor necrosis factor inhibitors for inflammatory bowel disease.用于炎症性肠病的肿瘤坏死因子抑制剂
N Engl J Med. 2013 Aug 22;369(8):754-62. doi: 10.1056/NEJMct1209614.
3
Letter by Lensen et al regarding article, "anti-tumor necrosis factor-α therapy reduces aortic inflammation and stiffness in patients with rheumatoid arthritis".伦森等人就“抗肿瘤坏死因子-α治疗可减轻类风湿关节炎患者的主动脉炎症和僵硬程度”一文所写的信。
Circulation. 2013 Jul 2;128(1):e10. doi: 10.1161/CIRCULATIONAHA.112.000549.
4
Response to letter regarding article, ''anti-tumor necrosis factor-α therapy reduces aortic inflammation and stiffness in patients with rheumatoid arthritis''.对关于文章《抗肿瘤坏死因子-α治疗可减轻类风湿关节炎患者的主动脉炎症和僵硬》的来信的回复
Circulation. 2013 Jul 2;128(1):e11. doi: 10.1161/circulationaha.113.002597.
5
Indoleamine 2,3-dioxygenase expression in human inflammatory bowel disease.人炎症性肠病中的吲哚胺 2,3-双加氧酶表达。
Eur J Gastroenterol Hepatol. 2012 Jun;24(6):695-701. doi: 10.1097/MEG.0b013e328351c1c2.
6
Evaluation of de-escalation of anti-TNF-α therapy in inflammatory bowel disease.炎症性肠病中抗TNF-α治疗方案降级的评估
Gastroenterol Hepatol. 2019 Feb;42(2):133-140. doi: 10.1016/j.gastrohep.2018.10.010. Epub 2018 Dec 27.
7
A Narrative Review on Anti-Tumor Necrosis Factor α Therapies in Inflammatory Bowel Disease During Pregnancy: Immunoglobulin Placental Translocation and its Impact.关于妊娠期炎症性肠病中抗肿瘤坏死因子α疗法的叙述性综述：免疫球蛋白的胎盘转运及其影响
Acta Med Port. 2019 Apr 30;32(4):305-312. doi: 10.20344/amp.11482.
8
Psoriasis associated with anti-tumour necrosis factor therapy in inflammatory bowel disease: a new series and a review of 120 cases from the literature.炎症性肠病患者接受肿瘤坏死因子拮抗剂治疗后出现银屑病：一项新的系列研究及对文献中 120 例病例的回顾。
Aliment Pharmacol Ther. 2011 Dec;34(11-12):1318-27. doi: 10.1111/j.1365-2036.2011.04866.x. Epub 2011 Sep 29.
9
Report of the ECCO workshop on anti-TNF therapy failures in inflammatory bowel diseases: biological roles and effects of TNF and TNF antagonists.炎症性肠病抗 TNF 治疗失败的 ECCO 研讨会报告：TNF 及其拮抗剂的生物学作用和影响。
J Crohns Colitis. 2010 Oct;4(4):367-76. doi: 10.1016/j.crohns.2010.05.011. Epub 2010 Jul 1.
10
[Cytokine and anti-cytokine therapy in chronic inflammatory bowel diseases].[慢性炎症性肠病中的细胞因子及抗细胞因子治疗]
Dtsch Med Wochenschr. 2001 Jun 1;126 Suppl 1:S52-8. doi: 10.1055/s-2001-14492.

引用本文的文献

1
Inflammation and Arterial Stiffness as Drivers of Cardiovascular Risk in Kidney Disease.炎症与动脉僵硬度作为肾脏疾病心血管风险的驱动因素
Cardiorenal Med. 2025;15(1):29-40. doi: 10.1159/000542965. Epub 2024 Dec 4.
2
Arterial structure and function in children with inflammatory bowel disease.炎症性肠病患儿的动脉结构与功能
JGH Open. 2024 Jun 3;8(6):e13100. doi: 10.1002/jgh3.13100. eCollection 2024 Jun.
3
Cardiovascular Comorbidities and Inflammatory Bowel Disease: Causes and Consequences.心血管合并症与炎症性肠病：病因与后果
Gastroenterol Hepatol (N Y). 2024 Apr;20(4):204-215.
4
Urotensin II levels in patients with inflammatory bowel disease.炎症性肠病患者的尾加压素 II 水平。
World J Gastroenterol. 2021 Sep 28;27(36):6142-6153. doi: 10.3748/wjg.v27.i36.6142.
5
Vascular consequences of inflammation: a position statement from the ESH Working Group on Vascular Structure and Function and the ARTERY Society.炎症的血管后果：ESH血管结构与功能工作组及动脉协会的立场声明
J Hypertens. 2020 Sep;38(9):1682-1698. doi: 10.1097/HJH.0000000000002508.